Revelation Biosciences (REVB) CFO Zygmont Receives 208,073 Restricted Shares

What Happened
Chester S. Zygmont III, Chief Financial Officer of Revelation Biosciences (REVB), was granted a restricted stock award for 208,073 shares on 2026-08-17 (recorded at $0.00). The same day the award is reported as disposed of by gift and acquired by gift—indicating the shares were transferred to related entities. No cash changed hands in the reported transactions.

Key Details

• Transaction date: 2026-08-17; Form 4 filed 2026-08-18 (timely; Form 4s are due within two business days).
• Award: 208,073 restricted shares granted (transaction code A) at $0.00.
• Transfers: 208,073 shares recorded as gifted (transaction code G) the same day.
• Holdings after transaction: The shares are held by entities described in the filing—The Zygmont Family Trust dated October 25, 2016 (Zygmont is a trustee) and Czeslaw Capital Fund, LLC (Zygmont is sole manager).
• Vesting/conditions (per footnote): Shares subject to Revelation Biosciences, Inc. 2021 Equity Incentive Plan; 50% vest at the two‑year anniversary and 50% at the four‑year anniversary, subject to continued service. Vesting may be accelerated upon achievement of certain performance milestones.
• No sale or cash purchase reported; the filing shows a grant followed by gift transfers.

Context

• This was a restricted stock award, not an open‑market purchase or sale. Because the shares were gifted to related entities, the transfers do not necessarily reflect the CFO’s personal buying/selling sentiment.
• Restricted shares subject to multi-year vesting schedules are common for executive compensation and align pay with continued service and performance milestones.